HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype

Blood

Volumn 103, Issue 7, 2004, Pages 2835-2840

  Jacolot, Sandrine ^b   Le Gac, Gerald ^b   Scotet, Virginie ^b   Quere, Isabelle ^b   Mura, Catherine ^b   Ferec, Claude ^a  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HFE PROTEIN;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENE EXPRESSION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HAMP GENE; HEMOCHROMATOSIS; HEREDITARY HEMOCHROMATOSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INHERITANCE; IRON METABOLISM; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; ONSET AGE; PRIORITY JOURNAL;

EID: 1642367900     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-10-3366     Document Type: Article

References (50)

1. Bothwell TH, Charlton RW, Motulsky AG. Hemochromatosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. Vol II. New York, NY: McGraw-Hill; 1995:2237-2269.
2. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399-408.
3. Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, Rochette J, Robson KJ. Geography of HFE C282Y and H63D mutations. Genet Test. 2000;4:183-198.
4. Wigg AJ, Harley H, Casey G. Heterozygous recipient and donor HFE mutations associated with a hereditary haemochromatosis phenotype after liver transplantation. Gut. 2003;52:433-435.
5. Liechti-Gallati S, Varga D, Reichen J. Screening for hemochomatosis in Switzerland: detection of a new pathogenic mutation and two additional variants in exon 2 of the HFE gene [abstract]. Eur J Hum Genet. 1999:122.
6. Mura C, Raguenes O, Ferec C. HFE mutation analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 1999;8:2502-2505.
7. Beutler E, Griffin M, Gelbart T, West C. A previously undescribed nonsense mutation of the HFE gene. Clin Genet. 2002;61:40-42.
8. Barton JC, Sawada-Hirai R, Rothenberg BE, Ronald TA. Two novel missense mutations of the HFE gene (I1O5T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands. Blood Cells Mol Dis. 1999;25:147-155.
9. Taylor S, Kinkley SM, Brown B, Lyng AT, Schep GN, Lillicrap P. Genetic analysis of a 22 bp deletion of the HFE gene [abstract]. Eur J Hum Genet. 2001;9:246.
10. Pointon JJ, Shearman JD, Merryweather-Clarke AT, Robson K. A single nucleotide deletion in the putative haemochromatosis gene in a patient who is negative for both the C282Y and H63D mutations [abstract]. Proc Int Symp Iron Biol Med. 1997;268.
11. Pointon JJ, Wallace DF, Merryweather-Clarke AT, Robson K. Uncommon mutations and polymorphisms in the hemochromatosis gene. Genet Test. 2000;4:151-161.
12. Lüthi U, Käser I, Reganass S, Huber AR. Mild hereditary hemochromatosis in a Swiss kindred with rare compound heterozygous HFE point mutation (H63D and E168Q) [abstract]. Blood. 2001;98:6b.
13. Piperno A, Arosio C, Fossati L, et al. Two novel missense mutations of the HFE gene in five unrelated Italian patients with hemochromatosis. Gastroenterology. 2000;119:441-445.
14. Imanishi H, Liu W, Cheng J, Ikeda N, Amuro Y, Hada T. Idiopathic hemochromatosis with the mutation of Ala176Val heterozygous for HFE gene. Int Med. 2001;40:479-483.
15. Wallace DF, Dooley JS, Walker AP. A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote. Gastroenterology. 1999;116:1409-1412.
16. Rosmorduc O, Poupon R, Nion L, et al. Differential HFE allele expression in hemochromatosis heterozygotes. Gastroenterology. 2000;119:1075-1086.
17. Le Gac G, Dupradeau F-Y, Mura C, et al. Phenotypic expression of the C282Y/Q283P compound heterozygosity in HFE and molecular modeling of the Q283P mutation effect. Blood Cells Mol Dis. 2003;30:231-237.
18. de Villiers J, Hillermann R, Loubser L, Kotze MJ. Spectrum of mutations in the HFE gene implicated in haemochromatosis and porphyria. Hum Mol Genet 1999;8:1517-1522.
19. Steiner M, Ocran K, Genschel J, et al. A homozygous hfe gene splice site mutation (IVS5+1 G→A) in a hereditary hemochromatosis patient of vietnamese origin. Gastroenterology. 2002;122:789-795.
20. Burke W, Imperatore G, McDonnell SM, Baron RC, Khoury MJ. Contribution of different HFE genotypes to iron overload disease: a pooled analysis. Genet Med. 2000;2:271-277.
21. Papanikolaou G, Samuels ME, Ludwig E, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet. 2004;36:77-82.
22. Roetto A, Papanikolaou G, Politou M, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet. 2003;33:21-22.
23. Bomford A. Genetics of haemochromatosis. Lancet. 2002;360:1673-1681.
24. Beutler E. Penetrance in hereditary hemochromatosis: the HFE Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis. Blood. 2003;101:3347-3350.
25. Scotet V, Merour MC, Mercier A-Y, et al. Hereditary haemochromatosis: effect of excessive alcohol consumption on the disease expression in patients homozygous for the C282Y mutation. Am J Epidemiol. 2003;158:129-134.
26. Levy JE, Montross LK, Andrews NC. Genes that modify the hemochromatosis phenotype in mice. J Clin Invest. 2000;105:1209-1216.
27. Fleming RE, Holden CC, Tomatsu S, et al. Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis. Proc Natl Acad Sci U S A. 2001;98:2707-2711.
28. Dupic F, Fruchon S, Bensaïd M, et al. Inactivation of the hemochromatosis gene differentially regulates duodenal expression of iron-related mRNAs between mouse strains. Gastroenterology. 2002;122:745-751.
29. Le Gac G, Mura C, Ferec C. Complete scanning of the hereditary hemochromatosis gene (HFE) by use of denaturing HPLC. Clin Chem. 2001;47:1633-1640.
30. Nicolas G, Viatte L, Bennoun M, Beaumont C, Kahn A, Vaulont S. Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis. 2002;29:327-335.
31. Hunter HN, Fulton DB, Ganz T, Vogel HJ. The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem. 2002;277:37597-37603.
32. Jacolot S, Le Gac G, Quere I, Mura C, Ferec C. Digenic alteration (HFE/HAMP) associated with adult hemochromatosis phenotype [abstract]. Eur J Hum Genet. 2003;11(suppl 1):56.
33. Merryweather-Clarke AT, Cadet E, Bomford A, et al. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum Mol Genet. 2003;12:2241-2247.
34. van de Loo J-WHP, Creemers JWM, Bright NA, Young BD, Roebroek AJM, Van de Ven WJM. Biosynthesis, distinct post-translational modifications, and functional characterization of lymphoma proprotein convertase. J Biol Chem. 1997;272:27116-27123.
35. The ADHR consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet. 2000;26:345-348.
36. Shimada T, Mizutani S, Muto T, et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A. 2001;98:6500-6505.
37. Lee PL, Gelbart T, West C, Halloran C, Felliti V, Beutler E. A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin. Blood Cells Mol Dis. 2001;27:783-802.
38. Majore S, Binni F, Ricerca BM, Brioli G, Grammatico P. Absence of hepcidin gene mutations in 10 Italian patients with primary iron overload. Haematologica. 2002;87:221-222.
39. Lee P, Gelbart T, West C, Halloran C, Beutler E. Seeking candidate mutations that affect iron homeostasis. Blood Cells Mol Dis. 2002;29:471-487.
40. Ming JE, Muenke M. Multiple hits during early embryonic development: digenic diseases and holoprosencephaly. Am J Hum Genet. 2002;71:1017-1032.
41. Adams PC. Non-expressing homozygotes for the C282Y hemochromatosis: minority or majority of cases? Mol Genet Metab. 2000;71:81-86.
42. Coppin H, Bensaid M, Fruchon S, Borot N, Blanche H, Roth MP. Longevity and carrying the C282Y mutation for hemochromatosis on the HFE gene: case control study of 492 French centenarians. Br Med J. 2003;327:132-133.
43. Nicolas G, Andrews NC, Kahn A, Vaulont S. Hepcidin, a candidate modifier of hemochromatosis phenotype in mice. Blood. 2004;103:2841-2843.
44. Nicolas G, Bennoun M, Devaux I, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A. 2001;98:8780-8785.
45. Nicolas G, Viatte L, Lou D-Q, et al. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet. 2003;34:97-101.
46. Bridle KR, Frazer DM, Wilkins SJ, et al. Disrupted hepidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet. 2003;361:669-673.
47. Muckenthaler M, Roy CN, Custodio AO, et al. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat Genet. 2003;34:102-107.
48. Drakesmith H, Sweetland E, Schimanski L, et al. The hemochromatosis protein HFE inhibits iron export from macrophages. Proc Natl Acad Sci U S A. 2002;99:15602-15607.
49. Trinder D, Olynyk JK, Sly WS, Morgan EH. Iron uptake from plasma transferrin by the duodenum is impaired in the Hfe knockout mouse. Proc Natl Acad Sci U S A. 2002;99:5622-5626.
50. Roy CN, Enns CA. Iron homeostasis: new tales from the crypt. Blood. 2000;96:4020-4027.